CRDF
Cardiff Oncology
$0.84
+$0.01 (+1.09%)Jul 27, 2026
Key metrics
The numbers that frame CRDF today
- Market cap
- $57.16M
- P/E (TTM)
- -1.3
- EV / FCF
- -1.3
- Gross margin
- 100%
- EV / Sales
- 93.8
- ROIC
- -123.4%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $0.80
- 52wk High
- $4.19
Growth
Revenue and earnings trend for CRDF
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about CRDF
Is Cardiff Oncology a good buy?
No. Cardiff Oncology has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case. We think Cardiff Oncology is selling at a very high price.
What is the market capitalization of CRDF?
Cardiff Oncology's market capitalization is $57.16M.
What is the P/E ratio for CRDF stock?
Cardiff Oncology's current P/E ratio is -1.3.
What is the 52-week high for CRDF stock?
The 52-week high for Cardiff Oncology is $4.19. The current close of $0.84 is 80% below that high.
What is the 52-week low for CRDF stock?
The 52-week low for Cardiff Oncology is $0.80. The current close of $0.84 is 4.5% above that low.
Does CRDF stock pay dividends?
Cardiff Oncology does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for CRDF?
Cardiff Oncology's Debt / Equity ratio is 0.02.